Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion type Assertion NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_head.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion description "[These results indicate that the c-myb gene in human colon cancer is one of the factors related to cisplatin resistance, and support the need to develop anti-cancer therapeutics based on oncogene-targeted antisense oligonucleotide technology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion evidence source_evidence_literature NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion SIO_000772 11410788 NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion wasDerivedFrom befree-20150227 NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.
- NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_assertion wasGeneratedBy ECO_0000203 NP580616.RAbmJ4YesEgPOQBM2LW7ivBS8rzLb9cv2Hgv_5l8m3nso130_provenance.